{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:09:46Z","timestamp":1793970586278,"version":"4.8.0"},"reference-count":255,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2023,1,3]]},"abstract":"<jats:p>Severe acute respiratory disease coronavirus 2 (SARS-CoV-2) is responsible for the coronavirus disease 2019 (COVID-19) pandemic. Although a primarily respiratory disease, recent reports indicate that it also affects the central nervous system (CNS). Over 25% of COVID-19 patients report neurological symptoms such as memory loss, anosmia, hyposmia, confusion, and headaches. The neurological outcomes may be a result of viral entry into the CNS and\/or resulting neuroinflammation, both of which underlie an elevated risk for Alzheimer\u2019s disease (AD). Herein, we ask: Is COVID-19 a risk factor for AD? To answer, we identify the literature and review mechanisms by which COVID-19-mediated neuroinflammation can contribute to the development of AD, evaluate the effects of acute versus chronic phases of infection, and lastly, discuss potential therapeutics to address the rising rates of COVID-19 neurological sequelae.<\/jats:p>","DOI":"10.3233\/jad-220800","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T04:50:03Z","timestamp":1667019003000},"page":"1-23","source":"Crossref","is-referenced-by-count":36,"title":["COVID-19 as a Risk Factor for Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"91","author":[{"given":"Mahdieh","family":"Golzari-Sorkheh","sequence":"first","affiliation":[{"name":"Department of Immunology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald F.","family":"Weaver","sequence":"additional","affiliation":[{"name":"Krembil Research Institute, University Health Network, Toronto, ON, Canada"},{"name":"Department of Chemistry, University of Toronto, Toronto, ON, Canada"},{"name":"Department of Pharmaceutical Chemistry, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Reed","sequence":"additional","affiliation":[{"name":"Krembil Research Institute, University Health Network, Toronto, ON, Canada"},{"name":"Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-220800_ref1","doi-asserted-by":"crossref","first-page":"100618","DOI":"10.1016\/j.cpcardiol.2020.100618","article-title":"COVID-19 and Multiorgan response","volume":"45","author":"Zaim","year":"2020","journal-title":"Curr Probl Cardiol"},{"key":"10.3233\/JAD-220800_ref2","doi-asserted-by":"crossref","first-page":"662786","DOI":"10.3389\/fnagi.2021.662786","article-title":"COVID-19, neuropathology, and aging: SARS-CoV-2 neurological infection, mechanism, and associated complications","volume":"13","author":"Kalra","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-220800_ref3","doi-asserted-by":"crossref","first-page":"175628642097800","DOI":"10.1177\/1756286420978004","article-title":"COVID-19 and cerebrovascular diseases: A comprehensive overview","volume":"13","author":"Tsivgoulis","year":"2020","journal-title":"Ther Adv Neurol Disord"},{"key":"10.3233\/JAD-220800_ref4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s13760-021-01691-5","article-title":"Demyelination as a result of an immune response in patients with COVID-19","volume":"121","author":"Shabani","year":"2021","journal-title":"Acta Neurol Belg"},{"key":"10.3233\/JAD-220800_ref5","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.4103\/1673-5374.327323","article-title":"SARS-CoV-2 involvement in central nervous system tissue damage","volume":"17","author":"Haidar","year":"2022","journal-title":"Neural Regen Res"},{"key":"10.3233\/JAD-220800_ref6","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1038\/s41467-022-30932-1","article-title":"Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: Potential implications for neurological symptoms in COVID-19","volume":"13","author":"Charnley","year":"2022","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-220800_ref7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.stemcr.2021.12.011","article-title":"The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2","volume":"17","author":"Krasemann","year":"2022","journal-title":"Stem Cell Rep"},{"key":"10.3233\/JAD-220800_ref8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41392-021-00719-9","article-title":"SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration","volume":"6","author":"Zhang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.3233\/JAD-220800_ref9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12974-020-01896-0","article-title":"Central nervous system complications associated with SARS-CoV-2 infection: Integrative concepts of pathophysiology and case reports","volume":"17","author":"Najjar","year":"2020","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-220800_ref10","doi-asserted-by":"crossref","first-page":"745789","DOI":"10.3389\/fmed.2021.745789","article-title":"Neuroinflammation and Its Impact on the pathogenesis of COVID-19","volume":"8","author":"Almutairi","year":"2021","journal-title":"Front Med"},{"key":"10.3233\/JAD-220800_ref11","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41586-022-04569-5","article-title":"SARS-CoV-2 is associated with changes in brain structure in UK Biobank","volume":"604","author":"Douaud","year":"2022","journal-title":"Nature"},{"key":"10.3233\/JAD-220800_ref12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-220800_ref13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5603\/PJNNS.a2021.0072","article-title":"Neuro-COVID-19: An insidious virus in action","volume":"56","author":"Bratosiewicz-W\u0105sik","year":"2022","journal-title":"Neurol Neurochir Pol"},{"key":"10.3233\/JAD-220800_ref14","doi-asserted-by":"crossref","first-page":"104090","DOI":"10.1016\/j.lpm.2021.104090","article-title":"Long-COVID: Cognitive deficits (brain fog) and brain lesions in non\u2013hospitalized patients","volume":"51","author":"Hugon","year":"2022","journal-title":"Presse Med"},{"key":"10.3233\/JAD-220800_ref15","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1111\/ene.15045","article-title":"Neuropathological findings from COVID-19 patients with neurological symptoms argue against a direct brain invasion of SARS-CoV-2: A critical systematic review","volume":"28","author":"Cosentino","year":"2021","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-220800_ref16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1126\/science.abm2052","article-title":"Nervous system consequences of COVID-19","volume":"375","author":"Spudich","year":"2022","journal-title":"Science"},{"key":"10.3233\/JAD-220800_ref17","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1474-4422(20)30221-0","article-title":"Neurological associations of COVID-19","volume":"19","author":"Ellul","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-220800_ref19","doi-asserted-by":"crossref","first-page":"593223","DOI":"10.3389\/fphys.2021.593223","article-title":"Pathogenesis of multiple organ injury in COVID-19 and potential therapeutic strategies","volume":"12","author":"Lopes-Pacheco","year":"2021","journal-title":"Front Physiol"},{"key":"10.3233\/JAD-220800_ref20","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian","year":"2021","journal-title":"Nat Med"},{"key":"10.3233\/JAD-220800_ref21","doi-asserted-by":"crossref","first-page":"e210830","DOI":"10.1001\/jamanetworkopen.2021.0830","article-title":"Sequelae in adults at 6 months after COVID-19 infection","volume":"4","author":"Logue","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.3233\/JAD-220800_ref22","doi-asserted-by":"crossref","first-page":"698169","DOI":"10.3389\/fmicb.2021.698169","article-title":"Long COVID or post-acute sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms","volume":"12","author":"Proal","year":"2021","journal-title":"Front Microbiol"},{"key":"10.3233\/JAD-220800_ref23","doi-asserted-by":"crossref","first-page":"813924","DOI":"10.3389\/fphys.2022.813924","article-title":"The musculoskeletal involvement after mild to moderate COVID-19 infection","volume":"13","author":"dos Santos","year":"2022","journal-title":"Front Physiol"},{"key":"10.3233\/JAD-220800_ref24","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1177\/00033197211053903","article-title":"Does COVID-19 cause hypertension?","volume":"73","author":"Akpek","year":"2022","journal-title":"Angiology"},{"key":"10.3233\/JAD-220800_ref25","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jamainternmed.2020.5313","article-title":"Clinical outcomes in young US adults hospitalized with COVID-19","volume":"181","author":"Cunningham","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.3233\/JAD-220800_ref26","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2020.12603","article-title":"Persistent symptoms in patientsafter acute COVID-19","volume":"324","author":"Carf\u00ec","year":"2020","journal-title":"JAMA"},{"key":"10.3233\/JAD-220800_ref27","doi-asserted-by":"crossref","first-page":"101019","DOI":"10.1016\/j.eclinm.2021.101019","article-title":"Characterizing long COVID in an international cohort: 7 months of symptoms and their impact","volume":"38","author":"Davis","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.3233\/JAD-220800_ref28","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: A cohort study","volume":"397","author":"Huang","year":"2021","journal-title":"Lancet"},{"key":"10.3233\/JAD-220800_ref29","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s15010-021-01666-x","article-title":"Long COVID, a comprehensive systematic scoping review","volume":"49","author":"Akbarialiabad","year":"2021","journal-title":"Infection"},{"key":"10.3233\/JAD-220800_ref30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jamaneurol.2022.0461","article-title":"One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: A longitudinal cohort study","volume":"79","author":"Liu","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-220800_ref31","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1093\/brain\/awab009","article-title":"Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19","volume":"144","author":"Hosp","year":"2021","journal-title":"Brain"},{"key":"10.3233\/JAD-220800_ref32","first-page":"00063","article-title":"Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis.jrm","volume":"52","author":"Ahmed","year":"2020","journal-title":"J Rehabil Med"},{"key":"10.3233\/JAD-220800_ref33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/thx.2004.030205","article-title":"Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors","volume":"60","author":"Hui","year":"2005","journal-title":"Thorax"},{"key":"10.3233\/JAD-220800_ref34","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12879-022-07062-6","article-title":"Post-acute COVID-19 syndrome in patients after 12 months from COVID-19 infection in Korea","volume":"22","author":"Kim","year":"2022","journal-title":"BMC Infect Dis"},{"key":"10.3233\/JAD-220800_ref35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s41983-021-00379-0","article-title":"Neurological sequelae of COVID-19: A review","volume":"57","author":"Peterson","year":"2021","journal-title":"Egypt J Neurol Psychiatr Neurosurg"},{"key":"10.3233\/JAD-220800_ref36","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/alz.12558","article-title":"Alzheimer\u2019s-like signaling in brains of COVID-19 patients","volume":"18","author":"Reiken","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220800_ref37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JAD-220717","article-title":"Association of COVID-19 with new-onset Alzheimer\u2019s disease","volume":"89","author":"Wang","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220800_ref38","first-page":"e2112131","article-title":"Global incidence of neurological manifestations amongpatients hospitalized with COVID-19\u2014 a report for theGCS-NeuroCOVID Consortium and the ENERGY Consortium","volume":"4","author":"Chou","year":"2021","journal-title":"JAMA NetwOpen"},{"key":"10.3233\/JAD-220800_ref39","doi-asserted-by":"crossref","first-page":"fcab168","DOI":"10.1093\/braincomms\/fcab168","article-title":"Spectrum risk factors and outcomes of neurological and psychiatric complications of COVID-19: A UK-wide cross-sectional surveillance study","volume":"3","author":"Ross Russell","year":"2021","journal-title":"Brain Commun"},{"key":"10.3233\/JAD-220800_ref40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41591-021-01647-5","article-title":"Post-acute neurological consequences of COVID-19: An unequal burden","volume":"28","author":"Nolen","year":"2022","journal-title":"Nat Med"},{"key":"10.3233\/JAD-220800_ref41","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1111\/ene.15307","article-title":"Neurological outcomes 1 year after COVID-19 diagnosis: A prospective longitudinal cohort study","volume":"29","author":"Rass","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-220800_ref42","doi-asserted-by":"crossref","first-page":"e2118717","DOI":"10.1001\/jamanetworkopen.2021.18717","article-title":"Self-reported memory problems 8 months after COVID-19 infection","volume":"4","author":"S\u00f8raas","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.3233\/JAD-220800_ref43","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.3233\/JAD-220800_ref44","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s42399-020-00453-3","article-title":"Non-hospitalized adults with COVID-19 differ noticeably from hospitalized adults in their demographic, clinical, and social characteristics","volume":"2","author":"Bergquist","year":"2020","journal-title":"SN Compr Clin Med"},{"key":"10.3233\/JAD-220800_ref45","first-page":"e2119335","article-title":"Post-acute sequelae of SARS-CoV-2 infection and subjective memory problems","volume":"4","author":"Oh","year":"2021","journal-title":"JAMA NetwOpen"},{"key":"10.3233\/JAD-220800_ref46","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/acn3.51350","article-title":"Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 \u201clong haulers.\u201d","volume":"8","author":"Graham","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"10.3233\/JAD-220800_ref47","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/acps.12336","article-title":"Risk of dementia and mild cognitive impairment in older people with subjective memory complaints: Meta-analysis","volume":"130","author":"Mitchell","year":"2014","journal-title":"Acta Psychiatr Scand"},{"key":"10.3233\/JAD-220800_ref48","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3389\/fimmu.2020.01949","article-title":"Overview of immune response during SARS-CoV-2 infection: Lessons from the past","volume":"11","author":"Shah","year":"2020","journal-title":"Front Immunol"},{"key":"10.3233\/JAD-220800_ref49","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3390\/biology10090829","article-title":"Type I interferons in COVID-19 pathogenesis","volume":"10","author":"Palermo","year":"2021","journal-title":"Biology"},{"key":"10.3233\/JAD-220800_ref50","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.3233\/JAD-220800_ref51","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 cytokine storm; what we know so far","volume":"11","author":"Ragab","year":"2020","journal-title":"Front Immunol"},{"key":"10.3233\/JAD-220800_ref52","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/s12967-020-02646-9","article-title":"The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome","volume":"18","author":"Blot","year":"2020","journal-title":"J Transl Med"},{"key":"10.3233\/JAD-220800_ref53","first-page":"168","article-title":"Olfactory transmucosal SARS-CoV-2 invasion as a port of centralnervous system entry in individuals with COVID-19","volume":"24","author":"Meinhardt","year":"2021","journal-title":"NatNeurosci"},{"key":"10.3233\/JAD-220800_ref54","doi-asserted-by":"crossref","first-page":"eabf8396","DOI":"10.1126\/scitranslmed.abf8396","article-title":"COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters","volume":"13","author":"de Melo","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-220800_ref55","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","article-title":"Neuropathology of patients with COVID-19 in Germany: A post-mortem case series","volume":"19","author":"Matschke","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-220800_ref56","doi-asserted-by":"crossref","first-page":"e20202135","DOI":"10.1084\/jem.20202135","article-title":"Neuroinvasion of SARS-CoV-2 in human and mouse brain","volume":"218","author":"Song","year":"2021","journal-title":"J Exp Med"},{"key":"10.3233\/JAD-220800_ref57","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-220800_ref58","doi-asserted-by":"crossref","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood\u2013brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.3233\/JAD-220800_ref60","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrn.2017.48","article-title":"Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease","volume":"18","author":"Kisler","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-220800_ref61","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00415-020-09929-7","article-title":"Understanding the neurotropiccharacteristics of SARS-CoV-2: From neurological manifestations ofCOVID-19 to potential neurotropic mechanisms","volume":"267","author":"Zhou","year":"2020","journal-title":"J Neurol"},{"key":"10.3233\/JAD-220800_ref62","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1111\/all.14429","article-title":"Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors","volume":"75","author":"Radzikowska","year":"2020","journal-title":"Allergy"},{"key":"10.3233\/JAD-220800_ref63","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/bph.13139","article-title":"Microglial M1\/M2 polarization and metabolic states: Microglia bioenergetics with acute polarization","volume":"173","author":"Orihuela","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.3233\/JAD-220800_ref64","doi-asserted-by":"crossref","first-page":"670298","DOI":"10.3389\/fncel.2021.670298","article-title":"Microglial implications inSARS-CoV-2 infection and COVID-19: Lessons from viral RNAneurotropism and possible relevance to Parkinson\u2019s disease","volume":"15","author":"Awogbindin","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JAD-220800_ref65","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/jcp.29937","article-title":"COVID-19 and olfactory dysfunction: A possible associative approach towards neurodegenerative diseases","volume":"236","author":"Mahalaxmi","year":"2021","journal-title":"J Cell Physiol"},{"key":"10.3233\/JAD-220800_ref66","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3233\/JAD-210660","article-title":"The NLRP3 inflammasome in the pathogenesis and treatment of Alzheimer\u2019s disease","volume":"84","author":"Golzari-Sorkheh","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220800_ref67","first-page":"175909142095496","article-title":"Severe acute respiratorysyndrome coronavirus 2 impact on the central nervous system: Areastrocytes and microglia main players or merely bystanders?","volume":"12","author":"Murta","year":"2020","journal-title":"ASNNeuro"},{"key":"10.3233\/JAD-220800_ref68","doi-asserted-by":"crossref","unstructured":"(2022) 2022 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 18, 700\u2013789.","DOI":"10.1002\/alz.12638"},{"key":"10.3233\/JAD-220800_ref69","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/pin.12520","article-title":"Plaque formation and the intraneuronal accumulation of \u03b2-amyloid in Alzheimer\u2019s disease: Intraneuronal accumulation of \u03b2-amyloid","volume":"67","author":"Takahashi","year":"2017","journal-title":"Pathol Int"},{"key":"10.3233\/JAD-220800_ref70","doi-asserted-by":"crossref","first-page":"E4502","DOI":"10.1073\/pnas.1317918110","article-title":"Regional variability of imaging biomarkers in autosomal dominant Alzheimer\u2019s disease","volume":"110","author":"Benzinger","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-220800_ref71","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-220800_ref72","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s42399-020-00715-0","article-title":"Care for older people with dementia during COVID-19 pandemic","volume":"3","author":"Emmerton","year":"2021","journal-title":"SN Compr Clin Med"},{"key":"10.3233\/JAD-220800_ref73","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3233\/JAD-220031","article-title":"Association of Alzheimer\u2019s disease with COVID-19 susceptibility and severe complications: A nationwide cohort study","volume":"87","author":"Chung","year":"2022","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220800_ref74","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3233\/JAD-200537","article-title":"Potential novel role of COVID-19 in Alzheimer\u2019s disease and preventative mitigation strategies","volume":"76","author":"Naughton","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220800_ref75","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s12035-020-02177-w","article-title":"Neurobiochemical cross-talk between COVID-19 and Alzheimer\u2019s disease","volume":"58","author":"Rahman","year":"2021","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-220800_ref76","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41582-021-00520-w","article-title":"Developing the ATX(N) classification for use across the Alzheimer disease continuum","volume":"17","author":"Hampel","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-220800_ref77","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","article-title":"Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis","volume":"77","author":"Karch","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-220800_ref78","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1007\/s12035-020-02094-y","article-title":"Understanding the immunologic characteristics of neurologic manifestations of SARS-CoV-2 and potential immunological mechanisms","volume":"57","author":"Mohammadi","year":"2020","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-220800_ref79","doi-asserted-by":"crossref","first-page":"8240","DOI":"10.1523\/JNEUROSCI.1808-05.2005","article-title":"Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines","volume":"25","author":"Koenigsknecht-Talboo","year":"2005","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-220800_ref80","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.3390\/ijms22052681","article-title":"Interactions of SARS-CoV-2 with the blood-brain barrier","volume":"22","author":"Erickson","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-220800_ref81","doi-asserted-by":"crossref","first-page":"13603","DOI":"10.3390\/ijms222413603","article-title":"SARS-CoV-2 exacerbates beta-amyloid neurotoxicity, inflammation and oxidative stress in Alzheimer\u2019s disease patients","volume":"22","author":"Chiricosta","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-220800_ref82","doi-asserted-by":"crossref","first-page":"e9505","DOI":"10.1371\/journal.pone.0009505","article-title":"The Alzheimer\u2019s disease-associated amyloid \u03b2-protein is an antimicrobial peptide","volume":"5","author":"Soscia","year":"2010","journal-title":"PLoS One"},{"key":"10.3233\/JAD-220800_ref83","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.3233\/JAD-220800_ref84","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.3390\/cells9071717","article-title":"Microglia: Agents of the CNS pro-inflammatory response","volume":"9","author":"Rodr\u00edguez-G\u00f3mez","year":"2020","journal-title":"Cells"},{"key":"10.3233\/JAD-220800_ref85","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1172\/JCI133737","article-title":"Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease","volume":"130","author":"Roy","year":"2020","journal-title":"J Clin Investig"},{"key":"10.3233\/JAD-220800_ref86","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41467-017-00769-0","article-title":"Mef2C restrains microglialinflammatory response and is lost in brain ageing in anIFN-I-dependent manner","volume":"8","author":"Deczkowska","year":"2017","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-220800_ref87","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1016\/S2666-5247(20)30115-4","article-title":"Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: A post-mortem study","volume":"1","author":"Hanley","year":"2020","journal-title":"Lancet Microbe"},{"key":"10.3233\/JAD-220800_ref88","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"21","author":"Akiyama","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-220800_ref89","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11481-020-09975-y","article-title":"SARS-COV2 alters blood brain barrier integrity contributing to neuro-inflammation","volume":"16","author":"Reynolds Jessica","year":"2021","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.3233\/JAD-220800_ref90","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03710-0","article-title":"Dysregulation of brain and choroid plexus cell types in severe COVID-19","volume":"595","author":"Yang","year":"2021","journal-title":"Nature"},{"key":"10.3233\/JAD-220800_ref91","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/psyg.12218","article-title":"Serum tumour necrosis factor-\u03b1 and interleukin-6 levels in Alzheimer\u2019s disease and mild cognitive impairment: Neuroinflammation in cognitive disorder","volume":"17","author":"Kim","year":"2017","journal-title":"Psychogeriatrics"},{"key":"10.3233\/JAD-220800_ref92","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-220800_ref93","first-page":"55","article-title":"Study of interleukin-6 production in Alzheimer\u2019s disease","volume":"49","author":"Cojocaru","year":"2011","journal-title":"Rom J Intern Med"},{"key":"10.3233\/JAD-220800_ref94","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nlm.2018.06.006","article-title":"IL-6 deficiency alters spatial memory in 4- and 24-month-old mice","volume":"155","author":"Bialuk","year":"2018","journal-title":"Neurobiol Learn Mem"},{"key":"10.3233\/JAD-220800_ref95","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.3201\/eid2609.202122","article-title":"Encephalopathy and encephalitis associated with cerebrospinal fluid cytokine alterations and coronavirus disease, Atlanta, Georgia, USA, 2020","volume":"26","author":"Benameur","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.3233\/JAD-220800_ref96","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/cid\/ciaa449","article-title":"Detectable serum severe acute respiratory syndrome coronavirus 2 viral load (RNAemia) is closely correlated with drastically elevated interleukin 6 level in critically ill patients with coronavirus disease 2019","volume":"71","author":"Chen","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.3233\/JAD-220800_ref97","doi-asserted-by":"crossref","first-page":"18951","DOI":"10.1073\/pnas.2009017117","article-title":"Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19","volume":"117","author":"Cauchois","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-220800_ref98","doi-asserted-by":"crossref","first-page":"756","DOI":"10.14336\/AD.2020.0601","article-title":"Age-induced NLRP3 inflammasome over-activation increases lethality of SARS-CoV-2 pneumonia in elderly patients","volume":"11","author":"Lara","year":"2020","journal-title":"Aging Dis"},{"key":"10.3233\/JAD-220800_ref99","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1007\/s11064-020-03121-z","article-title":"Mechanisms of NLRP3 inflammasome activation: Its role in the treatment of Alzheimer\u2019s disease","volume":"45","author":"Zhang","year":"2020","journal-title":"Neurochem Res"},{"key":"10.3233\/JAD-220800_ref100","doi-asserted-by":"crossref","first-page":"e101064","DOI":"10.15252\/embj.2018101064","article-title":"Systemic inflammation impairs microglial A\u03b2 clearance through NLRP 3 inflammasome","volume":"38","author":"Tejera","year":"2019","journal-title":"EMBO J"},{"key":"10.3233\/JAD-220800_ref101","doi-asserted-by":"crossref","first-page":"106414","DOI":"10.1016\/j.clineuro.2020.106414","article-title":"Possible immunity, inflammation, and oxidative stress mechanisms of Alzheimer\u2019s disease in COVID-19 patients","volume":"201","author":"Wang","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"10.3233\/JAD-220800_ref102","doi-asserted-by":"crossref","first-page":"612807","DOI":"10.3389\/fimmu.2021.612807","article-title":"Regulated intramembrane proteolysis of ACE2: A potential mechanism contributing to COVID-19 pathogenesis?","volume":"12","author":"Gonzalez","year":"2021","journal-title":"Front Immunol"},{"key":"10.3233\/JAD-220800_ref103","doi-asserted-by":"crossref","first-page":"110678","DOI":"10.1016\/j.biopha.2020.110678","article-title":"ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19","volume":"131","author":"Dong","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.3233\/JAD-220800_ref104","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1006\/viro.2000.0757","article-title":"Coronavirus spike proteins in viral entry and pathogenesis","volume":"279","author":"Gallagher","year":"2001","journal-title":"Virology"},{"key":"10.3233\/JAD-220800_ref105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.3233\/JAD-220800_ref106","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.3390\/ijms22041687","article-title":"Protein expression of angiotensin-converting enzyme 2 (ACE2) is upregulated in brains with Alzheimer\u2019s disease","volume":"22","author":"Ding","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-220800_ref107","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/j.jinf.2020.06.072","article-title":"Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer\u2019s disease","volume":"81","author":"Lim","year":"2020","journal-title":"J Infect"},{"key":"10.3233\/JAD-220800_ref108","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13195-016-0217-7","article-title":"Angiotensin-converting enzyme 2 is reduced in Alzheimer\u2019s disease in association with increasing amyloid-\u03b2 and tau pathology","volume":"8","author":"Kehoe","year":"2016","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-220800_ref109","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3233\/JAD-2011-110347","article-title":"Associations of anti-hypertensive treatments with Alzheimer\u2019s disease, vascular dementia, and other dementias","volume":"26","author":"Davies","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220800_ref110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41421-020-0147-1","article-title":"Comparative genetic analysis of the novel coronavirus (2019-nCoV\/SARS-CoV-2) receptor ACE2 in different populations","volume":"6","author":"Cao","year":"2020","journal-title":"Cell Discov"},{"key":"10.3233\/JAD-220800_ref111","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/archneur.57.2.210","article-title":"Association between angiotensin-converting enzyme and Alzheimer disease","volume":"57","author":"Farrer","year":"2000","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-220800_ref112","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1515\/cclm-2020-0425","article-title":"COVID-19 infections are also affected by human ACE1 D\/I polymorphism","volume":"58","author":"Delanghe","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"10.3233\/JAD-220800_ref113","doi-asserted-by":"crossref","first-page":"147032031666675","DOI":"10.1177\/1470320316666750","article-title":"Renin\u2013angiotensin system gene expression and neurodegenerative diseases","volume":"17","author":"Goldstein","year":"2016","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.3233\/JAD-220800_ref114","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1016\/S0021-9258(18)91039-2","article-title":"Synthesis, intracellular processing, and signal peptide of human apolipoprotein E","volume":"259","author":"Zannis","year":"1984","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-220800_ref115","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1016\/S0021-9258(18)34702-1","article-title":"Human apolipoprotein E. The complete amino acid sequence","volume":"257","author":"Rall","year":"1982","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-220800_ref116","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1016\/S0021-9258(20)82169-3","article-title":"Human apolipoprotein E mRNA. cDNA cloning and nucleotide sequencing of a new variant","volume":"259","author":"McLean","year":"1984","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-220800_ref117","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neuron.2020.10.008","article-title":"Apolipoprotein E: Structural insights and links to Alzheimer disease pathogenesis","volume":"109","author":"Chen","year":"2021","journal-title":"Neuron"},{"key":"10.3233\/JAD-220800_ref118","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1073\/pnas.91.12.5355","article-title":"Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases","volume":"91","author":"Perutz","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-220800_ref119","doi-asserted-by":"crossref","first-page":"104795","DOI":"10.1016\/j.nbd.2020.104795","article-title":"Apolipoprotein E and oxidative stress in brain with relevance to Alzheimer\u2019s disease","volume":"138","author":"Butterfield","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-220800_ref120","doi-asserted-by":"crossref","first-page":"102954","DOI":"10.1016\/j.ebiom.2020.102954","article-title":"ApolipoproteinE (APOE) genotype-associated disease risks: A phenome-wide,registry-based, case-control study utilising the UK Biobank","volume":"59","author":"Lumsden","year":"2020","journal-title":"eBioMedicine"},{"key":"10.3233\/JAD-220800_ref121","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/gerona\/glaa131","article-title":"APOE e4 genotype predicts severe COVID-19 in the UK Biobank Community Cohort","volume":"75","author":"Kuo","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.3233\/JAD-220800_ref122","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1164\/rccm.202001-0179LE","article-title":"Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2","volume":"202","author":"Zhao","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.3233\/JAD-220800_ref123","doi-asserted-by":"crossref","first-page":"2002049","DOI":"10.1183\/13993003.02049-2020","article-title":"Pathogenesis of COVID-19-induced ARDS: Implications for an ageing population","volume":"56","author":"Torres Acosta","year":"2020","journal-title":"Eur Respir J"},{"key":"10.3233\/JAD-220800_ref124","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jama.2020.4326","article-title":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State","volume":"323","author":"Arentz","year":"2020","journal-title":"JAMA"},{"key":"10.3233\/JAD-220800_ref125","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.3233\/JAD-220800_ref126","doi-asserted-by":"crossref","first-page":"724022","DOI":"10.3389\/fpsyg.2021.724022","article-title":"\u201cBrain fog\u201d by COVID-19 or Alzheimer\u2019s disease? A case report","volume":"12","author":"Matias-Guiu","year":"2021","journal-title":"Front Psychol"},{"key":"10.3233\/JAD-220800_ref127","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1164\/rccm.202006-2157CP","article-title":"Why COVID-19 silent hypoxemia is baffling to physicians","volume":"202","author":"Tobin","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.3233\/JAD-220800_ref128","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1007\/s11033-021-06358-1","article-title":"Silent hypoxia in COVID-19: Pathomechanism and possible management strategy","volume":"48","author":"Rahman","year":"2021","journal-title":"Mol Biol Rep"},{"key":"10.3233\/JAD-220800_ref129","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1017\/S1355617710001633","article-title":"Cognitive and functional outcome after out of hospital cardiac arrest","volume":"17","author":"Alexander","year":"2011","journal-title":"J Int Neuropsychol Soc"},{"key":"10.3233\/JAD-220800_ref130","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.resuscitation.2019.04.012","article-title":"Hippocampus and basal ganglia as potential sentinel sites for ischemic pathology after resuscitated cardiac arrest","volume":"139","author":"Haglund","year":"2019","journal-title":"Resuscitation"},{"key":"10.3233\/JAD-220800_ref131","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.brainres.2004.05.106","article-title":"Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein","volume":"1022","author":"Wen","year":"2004","journal-title":"Brain Res"},{"key":"10.3233\/JAD-220800_ref132","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMc2019373","article-title":"Neuropathological features of Covid-19","volume":"383","author":"Solomon","year":"2020","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-220800_ref133","doi-asserted-by":"crossref","first-page":"e2016","DOI":"10.1212\/WNL.0000000000010116","article-title":"Early postmortem brain MRI findings in COVID-19 non-survivors","volume":"95","author":"Coolen","year":"2020","journal-title":"Neurology"},{"key":"10.3233\/JAD-220800_ref134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-020-02166-2","article-title":"Neuropathology of COVID-19: A spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology","volume":"140","author":"Reichard","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-220800_ref135","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/svn-2020-000431","article-title":"Acute cerebrovascular disease following COVID-19: A single center, retrospective, observational study","volume":"5","author":"Li","year":"2020","journal-title":"Stroke Vasc Neurol"},{"key":"10.3233\/JAD-220800_ref136","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13098-020-00586-4","article-title":"Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: A meta-analysis","volume":"12","author":"de Almeida-Pititto","year":"2020","journal-title":"Diabetol Metab Syndr"},{"key":"10.3233\/JAD-220800_ref137","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00401-015-1522-0","article-title":"Cerebrovascular disease in ageing and Alzheimer\u2019s disease","volume":"131","author":"Love","year":"2016","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-220800_ref138","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1212\/WNL.53.6.1308","article-title":"APOE genotype as a riskfactor for ischemic cerebrovascular disease: A meta-analysis","volume":"53","author":"McCarron","year":"1999","journal-title":"Neurology"},{"key":"10.3233\/JAD-220800_ref139","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1212\/WNL.0b013e31829bfda4","article-title":"APOE genotype and MRI markers ofcerebrovascular disease: Systematic review and meta-analysis","volume":"81","author":"Schilling","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-220800_ref140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11883-004-0056-z","article-title":"Cardiovascular risk factors and Alzheimer\u2019s disease","volume":"6","author":"Luchsinger","year":"2004","journal-title":"Curr Atheroscler Rep"},{"key":"10.3233\/JAD-220800_ref141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/WAD.0b013e318187541c","article-title":"Cardiovascular risk factors and incident Alzheimer disease: A systematic review of the literature","volume":"23","author":"Purnell","year":"2009","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-220800_ref142","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.dadm.2017.01.005","article-title":"Pathophysiologic relationship between Alzheimer\u2019s disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis","volume":"7","author":"Santos","year":"2017","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.3233\/JAD-220800_ref143","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1097\/00002093-199912003-00017","article-title":"Overlap between pathology of Alzheimer disease and vascular dementia","volume":"13","author":"Kalaria","year":"1999","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-220800_ref144","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jns.2004.09.004","article-title":"Vascular pathologies and cognition in a population-based cohort of elderly people","volume":"226","author":"Fernando","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-220800_ref145","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00401-002-0634-5","article-title":"Incidence of cerebrovascular lesions in Alzheimer\u2019s disease: A postmortem study","volume":"105","author":"Jellinger","year":"2003","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-220800_ref146","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.neurobiolaging.2008.09.011","article-title":"Contribution of vascular pathology to the clinical expression of dementia","volume":"31","author":"Strozyk","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-220800_ref147","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/CIRCRESAHA.118.313400","article-title":"Cerebrovascular alterations in Alzheimer disease: Incidental or pathogenic?","volume":"123","author":"Iadecola","year":"2018","journal-title":"Circ Res"},{"key":"10.3233\/JAD-220800_ref148","doi-asserted-by":"crossref","first-page":"e13473","DOI":"10.1111\/apha.13473","article-title":"Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19","volume":"229","author":"Steardo","year":"2020","journal-title":"Acta Physiol"},{"key":"10.3233\/JAD-220800_ref149","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3390\/brainsci11030305","article-title":"COVID-19 and Alzheimer\u2019s disease","volume":"11","author":"Ciaccio","year":"2021","journal-title":"Brain Sci"},{"key":"10.3233\/JAD-220800_ref150","doi-asserted-by":"crossref","first-page":"613422","DOI":"10.3389\/fimmu.2021.613422","article-title":"Interleukin-6 is a biomarker for the development of fatal severe acute respiratory syndrome coronavirus 2 pneumonia","volume":"12","author":"Santa Cruz","year":"2021","journal-title":"Front Immunol"},{"key":"10.3233\/JAD-220800_ref151","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S2213-2600(20)30600-7","article-title":"Assessing the importance of interleukin-6 in COVID-19","volume":"9","author":"Chen","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.3233\/JAD-220800_ref152","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.medmal.2020.04.002","article-title":"Interleukin-6 as a potential biomarker of COVID-19 progression","volume":"50","author":"Ulhaq","year":"2020","journal-title":"Med Mal Infect"},{"key":"10.3233\/JAD-220800_ref153","first-page":"351","article-title":"Investigation of genetic variations of IL6 and IL6R as potential prognostic and pharmacogenetics biomarkers: Implications for COVID-19 and neuroinflammatory disorders","volume":"10","author":"Strafella","year":"2020","journal-title":"Life (Basel)"},{"key":"10.3233\/JAD-220800_ref154","doi-asserted-by":"crossref","first-page":"110267","DOI":"10.1016\/j.biopha.2020.110267","article-title":"Emerging pharmacotherapies for COVID-19","volume":"128","author":"Salvi","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.3233\/JAD-220800_ref155","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrd.2018.45","article-title":"Interleukin-6: Designing specific therapeutics for a complex cytokine","volume":"17","author":"Garbers","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JAD-220800_ref156","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12974-019-1439-y","article-title":"Genetic variabilityof inflammation and oxidative stress genes does not play a majorrole in the occurrence of adverse events of dopaminergic treatmentin Parkinson\u2019s disease","volume":"16","author":"Reden\u0161ek","year":"2019","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-220800_ref157","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mgene.2016.01.001","article-title":"Genetic polymorphisms of interleukin genes and the risk of Alzheimer\u2019s disease: An update meta-analysis","volume":"8","author":"Mun","year":"2016","journal-title":"Meta Gene"},{"key":"10.3233\/JAD-220800_ref158","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1172\/JCI67221","article-title":"IL-6 polymorphisms: A useful genetic tool for inflammation research?","volume":"123","author":"Woo","year":"2013","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-220800_ref159","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJMoa2100433","article-title":"Interleukin-6 receptor antagonists in critically ill patients with Covid-19","volume":"384","author":"The REMAP-CAP Investigators","year":"2021","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-220800_ref160","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jama.2021.11330","article-title":"Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: A meta-analysis","volume":"326","author":"Domingo","year":"2021","journal-title":"JAMA"},{"key":"10.3233\/JAD-220800_ref161","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41420-019-0181-7","article-title":"SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes","volume":"5","author":"Shi","year":"2019","journal-title":"Cell Death Discov"},{"key":"10.3233\/JAD-220800_ref162","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.3233\/JAD-220800_ref163","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: Consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.3233\/JAD-220800_ref164","doi-asserted-by":"crossref","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","article-title":"Interleukin-1 blockade with high-dose anakinra inpatients with COVID-19, acute respiratory distress syndrome, andhyperinflammation: A retrospective cohort study","volume":"2","author":"Cavalli","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"10.3233\/JAD-220800_ref165","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12974-018-1376-1","article-title":"Circulating levels of IL-1 family cytokines and receptors in Alzheimer\u2019s disease: New markers of disease progression?","volume":"15","author":"Italiani","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-220800_ref166","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1189\/jlb.72.2.233","article-title":"Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer\u2019s disease","volume":"72","author":"Griffin","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.3233\/JAD-220800_ref167","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0197-4580(96)00104-2","article-title":"In vivo and in vitro evidence supporting a role for the inflammatory cytokine interleukin-1 as a driving force in Alzheimer pathogenesis","volume":"17","author":"Sheng","year":"1996","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-220800_ref168","doi-asserted-by":"crossref","first-page":"6539","DOI":"10.4049\/jimmunol.1100620","article-title":"Blocking IL-1 signaling rescues cognition, attenuates tau pathology, and restores neuronal \u03b2-catenin pathway function in an Alzheimer\u2019s disease model","volume":"187","author":"Kitazawa","year":"2011","journal-title":"J Immunol"},{"key":"10.3233\/JAD-220800_ref169","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0149-7634(00)00048-8","article-title":"The immune system and memory consolidation: A role for the cytokine IL-1\u03b2","volume":"25","author":"Rachal Pugh","year":"2001","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JAD-220800_ref170","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/hipo.10164","article-title":"Learning modulation by endogenous hippocampal IL-1: Blockade of endogenous IL-1 facilitates memory formation","volume":"14","author":"Depino","year":"2004","journal-title":"Hippocampus"},{"key":"10.3233\/JAD-220800_ref171","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.psyneuen.2007.09.004","article-title":"A dual role for interleukin-1 in hippocampal-dependent memory processes","volume":"32","author":"Goshen","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.3233\/JAD-220800_ref172","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s001090050232","article-title":"Galectins: Versatile modulators of cell adhesion, cell proliferation, and cell death","volume":"76","author":"Perillo","year":"1998","journal-title":"J Mol Med"},{"key":"10.3233\/JAD-220800_ref173","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nri2536","article-title":"Turning \u201csweet\u201d on immunity: Galectin-glycan interactions in immune tolerance and inflammation","volume":"9","author":"Rabinovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.3233\/JAD-220800_ref174","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/978-1-4939-1154-7_24","article-title":"Galectins and neuroinflammation","volume":"9","author":"Chen","year":"2014","journal-title":"Adv Neurobiol"},{"key":"10.3233\/JAD-220800_ref175","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13578-021-00592-7","article-title":"Galectin-3: A key player in microglia-mediated neuroinflammation and Alzheimer\u2019s disease","volume":"11","author":"Tan","year":"2021","journal-title":"Cell Biosci"},{"key":"10.3233\/JAD-220800_ref176","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fncel.2020.00162","article-title":"Sialylation and galectin-3 in microglia-mediated neuroinflammation and neurodegeneration","volume":"14","author":"Puigdell\u00edvol","year":"2020","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JAD-220800_ref177","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13024-017-0188-6","article-title":"Microglia limit theexpansion of \u03b2-amyloid plaques in a mouse model of Alzheimer\u2019s disease","volume":"12","author":"Zhao","year":"2017","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-220800_ref178","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/art.24574","article-title":"Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways","volume":"60","author":"Filer","year":"2009","journal-title":"Arthritis Rheumatol"},{"key":"10.3233\/JAD-220800_ref179","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1600-065X.2009.00794.x","article-title":"The regulation of inflammation by galectin 3","volume":"230","author":"Henderson","year":"2009","journal-title":"Immunol Rev"},{"key":"10.3233\/JAD-220800_ref180","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.3389\/fimmu.2020.02069","article-title":"Hyperinflammation and fibrosis in severe COVID-19 patients: Galectin-3, a target molecule to consider","volume":"11","author":"Garcia-Revilla","year":"2020","journal-title":"Front Immunol"},{"key":"10.3233\/JAD-220800_ref181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/9247574","article-title":"The many roles of galectin-3, a multifaceted molecule, in innate immune responses against pathogens","volume":"2017","author":"D\u00edaz-Alvarez","year":"2017","journal-title":"Mediators Inflamm"},{"key":"10.3233\/JAD-220800_ref182","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.4049\/jimmunol.165.4.2156","article-title":"Human galectin-3 is a novel chemoattractant for monocytes and macrophages","volume":"165","author":"Sano","year":"2000","journal-title":"J Immunol"},{"key":"10.3233\/JAD-220800_ref183","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/ecco-jcc\/jjw013","article-title":"Galectin-3 plays an important pro-inflammatory role in the induction phase of acute colitis by promoting activation of NLRP3 inflammasome and production of IL-1\u03b2 in macrophages","volume":"10","author":"Simovic Markovic","year":"2016","journal-title":"J Crohns Colitis"},{"key":"10.3233\/JAD-220800_ref184","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.4049\/jimmunol.156.10.3939","article-title":"Galectin-3 promotes adhesion of human neutrophils to laminin","volume":"156","author":"Kuwabara","year":"1996","journal-title":"J Immunol"},{"key":"10.3233\/JAD-220800_ref185","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/SHK.0000000000000757","article-title":"The Predictive value of plasma galectin-3 for Ards severity and clinical outcome","volume":"47","author":"Xu","year":"2017","journal-title":"Shock"},{"key":"10.3233\/JAD-220800_ref186","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1038\/s41598-022-05968-4","article-title":"Galectin-3 as a potential prognosticbiomarker of severe COVID-19 in SARS-CoV-2 infected patients","volume":"12","author":"Cervantes-Alvarez","year":"2022","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-220800_ref187","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41418-019-0348-z","article-title":"Galectin-3 promotes A\u03b2 oligomerization and A\u03b2 toxicity in a mouse model of Alzheimer\u2019s disease","volume":"27","author":"Tao","year":"2020","journal-title":"Cell Death Differ"},{"key":"10.3233\/JAD-220800_ref188","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1038\/s41467-019-11441-0","article-title":"Galectin-3 is required for the microglia-mediated brain inflammation in a model of Huntington\u2019s disease","volume":"10","author":"Siew","year":"2019","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-220800_ref189","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ajpath.2017.12.014","article-title":"Galectin-3 enhances avian H5N1 influenza A virus\u2013induced pulmonary inflammation by promoting NLRP3 inflammasome activation","volume":"188","author":"Chen","year":"2018","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-220800_ref190","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jmii.2019.09.005","article-title":"The role of galectins in virus infection - A systemic literature review","volume":"53","author":"Wang","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.3233\/JAD-220800_ref191","doi-asserted-by":"crossref","first-page":"e00384","DOI":"10.1128\/mBio.00384-21","article-title":"Galectin-9, a player in cytokine release syndrome and a surrogate diagnostic biomarker in SARS-CoV-2 infection","volume":"12","author":"Bozorgmehr","year":"2021","journal-title":"mBio"},{"key":"10.3233\/JAD-220800_ref192","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12974-014-0144-0","article-title":"Astrocyte galectin-9 potentiates microglial TNF secretion","volume":"11","author":"Steelman","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.3233\/JAD-220800_ref193","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpsychires.2019.10.002","article-title":"Increased ileal bile acid binding protein and galectin-9 are associated with mild cognitive impairment and Alzheimer\u2019s disease","volume":"119","author":"Wang","year":"2019","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-220800_ref194","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/alz.12556","article-title":"Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer\u2019s dementia","volume":"18","author":"Frontera","year":"2022","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220800_ref195","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1089\/neu.2010.1653","article-title":"Elevated serum ubiquitin carboxy-terminal hydrolase L1 is associated with abnormal blood-brain barrier function after traumatic brain injury","volume":"28","author":"Blyth","year":"2011","journal-title":"J Neurotrauma"},{"key":"10.3233\/JAD-220800_ref196","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1021\/bi972274d","article-title":"Substrate specificity of deubiquitinating enzymes: Ubiquitin C-terminal hydrolases","volume":"37","author":"Larsen","year":"1998","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-220800_ref197","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/neu.2015.4333","article-title":"Increases of plasma levels of glial fibrillary acidic protein, tau, and amyloid \u03b2 up to 90 days after traumatic brain injury","volume":"34","author":"Bogoslovsky","year":"2017","journal-title":"J Neurotrauma"},{"key":"10.3233\/JAD-220800_ref198","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1089\/neu.2017.5553","article-title":"Longitudinal performance of plasma neurofilament light and tau in professional fighters: The Professional Fighters Brain Health Study","volume":"35","author":"Bernick","year":"2018","journal-title":"J Neurotrauma"},{"key":"10.3233\/JAD-220800_ref199","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJMc2033369","article-title":"Microvascular injury in the brains of patients with Covid-19","volume":"384","author":"Lee","year":"2021","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-220800_ref200","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3390\/cells10020386","article-title":"Characterization and biomarker analyses of post-COVID-19 complications and neurological manifestations","volume":"10","author":"Sun","year":"2021","journal-title":"Cells"},{"key":"10.3233\/JAD-220800_ref201","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.201709069","article-title":"Microglia in Alzheimer\u2019s disease","volume":"217","author":"Hansen","year":"2018","journal-title":"J Cell Biol"},{"key":"10.3233\/JAD-220800_ref202","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3390\/biom10101439","article-title":"Microglia in Alzheimer\u2019s disease in the context of tau pathology","volume":"10","author":"Perea","year":"2020","journal-title":"Biomolecules"},{"key":"10.3233\/JAD-220800_ref203","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev-immunol-042718-041417","article-title":"Neuroinflammation during RNA viral infections","volume":"37","author":"Klein","year":"2019","journal-title":"Annu Rev Immunol"},{"key":"10.3233\/JAD-220800_ref204","first-page":"2143","article-title":"Inflammatory response leads to neuronal death in humanpost-mortem cerebral cortex in patients with COVID-19","volume":"12","author":"Boroujeni","year":"2021","journal-title":"ACS ChemNeurosci"},{"key":"10.3233\/JAD-220800_ref205","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1474-4422(18)30232-1","article-title":"Therole of TREM2 in Alzheimer\u2019s disease and other neurodegenerativedisorders","volume":"17","author":"Carmona","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-220800_ref206","doi-asserted-by":"crossref","first-page":"111438","DOI":"10.1016\/j.mad.2021.111438","article-title":"TREM2, microglia, and Alzheimer\u2019s disease","volume":"195","author":"Qin","year":"2021","journal-title":"Mech Ageing Dev"},{"key":"10.3233\/JAD-220800_ref207","first-page":"e14697","article-title":"Evaluation of the relationship between TREM-1\/TREM-2 ratioand clinical course in COVID-19 pneumonia","volume":"75","author":"Kerget","year":"2021","journal-title":"Int J Clin Pract"},{"key":"10.3233\/JAD-220800_ref208","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1126\/sciadv.abi6802","article-title":"TREM-2 is a sensor andactivator of T cell response in SARS-CoV-2 infection.eabi","volume":"7","author":"Wu","year":"2021","journal-title":"Sci Adv"},{"key":"10.3233\/JAD-220800_ref209","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nat Med"},{"key":"10.3233\/JAD-220800_ref210","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41586-019-1631-3","article-title":"Resolving the fibrotic niche of human liver cirrhosis at single-cell level","volume":"575","author":"Ramachandran","year":"2019","journal-title":"Nature"},{"key":"10.3233\/JAD-220800_ref211","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00401-019-02013-z","article-title":"Galectin-3, a novel endogenous TREM2 ligand,detrimentally regulates inflammatory response in Alzheimer\u2019sdisease","volume":"138","author":"Boza-Serrano","year":"2019","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-220800_ref213","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fncel.2019.00363","article-title":"Brain-derived neurotrophic factor: A key molecule for memory in the healthy and the pathological brain","volume":"13","author":"Miranda","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JAD-220800_ref214","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fphar.2018.00237","article-title":"Inhibition of NMDA receptors prevents the loss of BDNF function induced by amyloid \u03b2","volume":"9","author":"Tanqueiro","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.3233\/JAD-220800_ref215","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.celrep.2019.06.054","article-title":"Deficiency in BDNF\/TrkB neurotrophic activity stimulates \u03b4-secretase by upregulating C\/EBP\u03b2 in Alzheimer\u2019s disease","volume":"28","author":"Wang","year":"2019","journal-title":"Cell Rep"},{"key":"10.3233\/JAD-220800_ref216","doi-asserted-by":"crossref","first-page":"16024","DOI":"10.1038\/npjamd.2016.24","article-title":"Deficiency of angiotensin-converting enzyme 2 causes deterioration of cognitive function","volume":"2","author":"Wang","year":"2016","journal-title":"NPJ Aging Mech Dis"},{"key":"10.3233\/JAD-220800_ref217","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pbb.2016.06.010","article-title":"Angiotensin II type 1 receptor blockade by telmisartan prevents stress-induced impairment of memory via HPA axis deactivation and up-regulation of brain-derived neurotrophic factor gene expression","volume":"148","author":"Wincewicz","year":"2016","journal-title":"Pharmacol Biochem Behav"},{"key":"10.3233\/JAD-220800_ref218","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/1073858420967892","article-title":"Why severe COVID-19 patients are at greater risk of developing depression: A molecular perspective","volume":"28","author":"Bou\u00e7as","year":"2022","journal-title":"Neuroscientist"},{"key":"10.3233\/JAD-220800_ref219","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1097\/INF.0000000000002834","article-title":"Multisystem inflammatory syndrome associated with COVID-19 with neurologic manifestations in a child: A brief report","volume":"39","author":"De Paulis","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"10.3233\/JAD-220800_ref220","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1016\/j.jinf.2020.06.038","article-title":"Recovery from SARS-CoV-2 infection is associated with serum BDNF restoration","volume":"81","author":"Azoulay","year":"2020","journal-title":"J Infect"},{"key":"10.3233\/JAD-220800_ref221","doi-asserted-by":"crossref","first-page":"784429","DOI":"10.3389\/fnut.2021.784429","article-title":"COVID-19 outcome relates with circulating BDNF, according to patient adiposity and age","volume":"8","author":"Minuzzi","year":"2021","journal-title":"Front Nutr"},{"key":"10.3233\/JAD-220800_ref222","doi-asserted-by":"crossref","first-page":"2100377","DOI":"10.1183\/13993003.00377-2021","article-title":"Between inflammation and thrombosis: Endothelial cells in COVID-19","volume":"58","author":"Birnhuber","year":"2021","journal-title":"Eur Respir J"},{"key":"10.3233\/JAD-220800_ref223","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41392-020-00454-7","article-title":"Endothelial activation and dysfunction in COVID-19: From basic mechanisms to potential therapeutic approaches","volume":"5","author":"Jin","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.3233\/JAD-220800_ref224","doi-asserted-by":"crossref","first-page":"e057892","DOI":"10.1002\/alz.057892","article-title":"Plasma biomarkers of neurodegeneration and neuroinflammation in hospitalized COVID-19 patients with and without new neurological symptoms","volume":"17","author":"Boutajangout","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220800_ref225","doi-asserted-by":"crossref","first-page":"646908","DOI":"10.3389\/fnagi.2021.646908","article-title":"Heterogeneity in regional damage detected by neuroimaging and neuropathological studies in older adults with COVID-19: A cognitive-neuroscience systematic review to inform the long-term impact of the virus on neurocognitive trajectories","volume":"13","author":"Manca","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-220800_ref226","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMc2008597","article-title":"Neurologic features in severe SARS-CoV-2 infection","volume":"382","author":"Helms","year":"2020","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-220800_ref229","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac443"},{"key":"10.3233\/JAD-220800_ref230","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa2116044","article-title":"Molnupiravir for oral treatment of Covid-19 in nonhospitalized patients","volume":"386","author":"Jayk Bernal","year":"2022","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-220800_ref231","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1080\/07853890.2022.2034936","article-title":"Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19: A meta-analysis","volume":"54","author":"Wen","year":"2022","journal-title":"Ann Med"},{"key":"10.3233\/JAD-220800_ref232","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMoa2118691","article-title":"Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection","volume":"386","author":"Hall","year":"2022","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-220800_ref233","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12916-022-02397-y","article-title":"Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: A systematic review and meta-analysis","volume":"20","author":"Zeng","year":"2022","journal-title":"BMC Med"},{"key":"10.3233\/JAD-220800_ref234","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jinf.2022.06.011","article-title":"COVID-19 \u201cRebound\u201d associated with nirmatrelvir\/ritonavir pre-hospital therapy","volume":"85","author":"Coulson","year":"2022","journal-title":"J Infect"},{"key":"10.3233\/JAD-220800_ref235","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41594-021-00657-8","article-title":"Molnupiravir: Coding for catastrophe","volume":"28","author":"Malone","year":"2021","journal-title":"Nat Struct Mol Biol"},{"key":"10.3233\/JAD-220800_ref236","doi-asserted-by":"crossref","first-page":"o926","DOI":"10.1136\/bmj.o926","article-title":"Covid-19: What is the evidence for the antiviral molnupiravir?","volume":"377","author":"Extance","year":"2022","journal-title":"BMJ"},{"key":"10.3233\/JAD-220800_ref237","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/ane.13551","article-title":"Microglia and immunotherapy in Alzheimer\u2019s disease","volume":"145","author":"Li","year":"2022","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JAD-220800_ref238","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2147\/CIA.S357558","article-title":"Neuroinflammation as a potential therapeutic target in Alzheimer\u2019s disease","volume":"17","author":"Liu","year":"2022","journal-title":"Clin Interv Aging"},{"key":"10.3233\/JAD-220800_ref239","doi-asserted-by":"crossref","first-page":"815347","DOI":"10.3389\/fnagi.2022.815347","article-title":"Microglia polarization from M1 to M2 in neurodegenerative diseases","volume":"14","author":"Guo","year":"2022","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-220800_ref240","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.3390\/cells11121925","article-title":"New insights into neuroinflammation involved in pathogenic mechanism of Alzheimer\u2019s disease and its potential for therapeutic intervention","volume":"11","author":"Li","year":"2022","journal-title":"Cells"},{"key":"10.3233\/JAD-220800_ref241","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/1567202611666140609144347","article-title":"Editor\u2019s Perspective: \u201cConnecting the dots\u201d from blood brain barrier dysfunction to neuroinflammation and Alzheimer\u2019s disease","volume":"11","author":"Maiese","year":"2014","journal-title":"Curr Neurovasc Res"},{"key":"10.3233\/JAD-220800_ref245","doi-asserted-by":"crossref","first-page":"e9533","DOI":"10.7717\/peerj.9533","article-title":"Small molecule therapeutics for COVID-19: Repurposing of inhaled furosemide","volume":"8","author":"Wang","year":"2020","journal-title":"PeerJ"},{"key":"10.3233\/JAD-220800_ref246","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.amjms.2020.05.044","article-title":"Is inhaled furosemide a potential therapeutic for COVID-19?","volume":"360","author":"Brennecke","year":"2020","journal-title":"Am J Med Sci"},{"key":"10.3233\/JAD-220800_ref247","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1016\/j.jinf.2020.08.045","article-title":"Early short-coursecorticosteroids and furosemide combination to treat non-criticallyill COVID-19 patients: An observational cohort study","volume":"82","author":"Kevorkian","year":"2021","journal-title":"J Infect"},{"key":"10.3233\/JAD-220800_ref249","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1021\/acschemneuro.0c00445","article-title":"Furosemide as a probe molecule for the treatment of neuroinflammation in Alzheimer\u2019s disease","volume":"11","author":"Wang","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"10.3233\/JAD-220800_ref250","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.neurobiolaging.2014.05.002","article-title":"Use of diuretics is associated with reduced risk of Alzheimer\u2019s disease: The Cache County Study","volume":"35","author":"Chuang","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-220800_ref251","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/HJH.0000000000000868","article-title":"Diuretic antihypertensive drugs and incident dementia risk: A systematic review, meta-analysis and meta-regression of prospective studies","volume":"34","author":"Tully","year":"2016","journal-title":"J Hypertens"},{"key":"10.3233\/JAD-220800_ref252","doi-asserted-by":"crossref","first-page":"113565","DOI":"10.1016\/j.ejmech.2021.113565","article-title":"Design, synthesis, and biological evaluation of furosemide analogs as therapeutics for the proteopathy and immunopathy of Alzheimer\u2019s disease","volume":"222","author":"Wang","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.3233\/JAD-220800_ref253","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study 2019","volume":"7","author":"GBD 2019 Dementia Forecasting Collaborators","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.3233\/JAD-220800_ref255","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbi.2020.03.031","article-title":"Nervous system involvement after infection with COVID-19 and other coronaviruses","volume":"87","author":"Wu","year":"2020","journal-title":"Brain Behav Immun"},{"key":"10.3233\/JAD-220800_ref256","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1474-4422(14)70017-1","article-title":"Long-term cerebral consequences of sepsis","volume":"13","author":"Widmann","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-220800_ref257","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/jama.2010.1553","article-title":"Long-term cognitive impairment and functional disability among survivors of severe sepsis","volume":"304","author":"Iwashyna","year":"2010","journal-title":"JAMA"},{"key":"10.3233\/JAD-220800_ref258","doi-asserted-by":"crossref","first-page":"730727","DOI":"10.3389\/fnagi.2021.730727","article-title":"Intercepting dementia: Awareness and innovation as key tools","volume":"13","author":"Brai","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-220800_ref259","doi-asserted-by":"crossref","first-page":"204062232210768","DOI":"10.1177\/20406223221076890","article-title":"Neurological manifestations of long-COVID syndrome: A narrative review","volume":"13","author":"Stefanou","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"key":"10.3233\/JAD-220800_ref260","doi-asserted-by":"crossref","first-page":"698184","DOI":"10.3389\/fnagi.2021.698184","article-title":"Dementia as risk factor for severe coronavirus disease 2019: A case-control study","volume":"13","author":"Pisaturo","year":"2021","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-220800_ref261","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/alz.12296","article-title":"COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US","volume":"17","author":"Wang","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-220800_ref262","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3233\/JAD-210050","article-title":"Clinical features and outcomes of patients with dementia compared to an aging cohort hospitalized during the initial New York City COVID-19 wave","volume":"81","author":"Harb","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-220800_ref263","doi-asserted-by":"crossref","first-page":"523","DOI":"10.30773\/pi.2021.0064","article-title":"Association between dementia and clinical outcome after COVID-19: A nationwide cohort study with propensity score matched control in South Korea","volume":"18","author":"Wang","year":"2021","journal-title":"Psychiatry Investig"},{"key":"10.3233\/JAD-220800_ref264","doi-asserted-by":"crossref","first-page":"101052","DOI":"10.1016\/j.ssmph.2022.101052","article-title":"The rising burden of Alzheimer\u2019s disease mortality in rural America","volume":"17","author":"Ho","year":"2022","journal-title":"SSM - Popul Health"},{"key":"10.3233\/JAD-220800_ref265","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.37765\/ajmc.2020.88482","article-title":"Economic burden of Alzheimer disease and managed care considerations","volume":"26","author":"Wong","year":"2020","journal-title":"Am J Manag Care"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-220800","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:03Z","timestamp":1777370883000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-220800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":255,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-220800","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,3]]}}}